JHLT Earns Number One Ranking in Transplantation Journals

Published 04 August 2020
  • JHLT
  • Press Release
  • Publications & Journals

Sixth Year as Top Journal for JHLT

JHLT icon logoADDISON, TX – 4 August, 2020 – For the sixth year in a row, The Journal of Heart and Lung Transplantation’s Impact Factor earned the publication the number one ranking in the transplantation category. In addition, the Journal also ranked number four in Surgery, number seven in Respiratory and number 13 in the highly competitive Cardiovascular category.

Headshot of Mandeep Mehra“We are thrilled to see the Journal continuing to grow its influence and reach,” said Mandeep R. Mehra, MD, Editor in Chief, and the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital and Harvard Medical School. “We are proud our influence extends to so many disciplines -- and around the world.”

JHLT is the official publication of the International Society for Heart and Lung Transplantation (ISHLT). ISHLT is the only international interdisciplinary organization focused on interventions for advanced heart and lung disease, including transplantation.

The Impact Factor is published in the annual Journal Citation Reports (JCR). The calculation is determined by the number of 2019 citations accumulated for JHLT manuscripts published in the previous two years.

JHLT’s overall impact factor was 7.865 and the Immediacy index, a measure of how much attention papers get shortly after publication and citation, has increased substantially to 2.3.

In 2019, JHLT had 12,465 citations which is a 42 percent increase from 2015. In addition, the article Influence score, a measure of how much attention a paper published in the JHLT would acquire when normalized for categories, has risen to 2.906.

About ISHLT
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.